Julia K. Levine ILC Research Library

The Lobular Breast Cancer Alliance (LBCA) has compiled a reference list of research publications related to lobular breast cancer, also known as invasive lobular carcinoma (ILC).

This research library contains over 350 studies from the year 2000 to the present. The table that follows is our complete collection of studies. 

Publications and Articles

Studies added most recently are featured in alphabetical order under the New Additions headline at the beginning of the Publications and Articles list below. This is followed by previously added studies. The research library is updated periodically. 

How to use this table: Use the column headers to sort by category. Use the search function to locate specific study topics. To read a full article with restricted access, consult a local medical library or purchase access to the full article. LBCA cannot send or link to restricted articles due to license limitations. Suggestions for additions or changes to this list can be emailed to info@lobularbreastcancer.org for review. People with lobular breast cancer utilizing this research library are encouraged to discuss all studies with their providers. 

Last updated September 2026.  

AuthorTitlePublicationDateType of ArticleeGeneral SubjecttSpecific
Subject
SottnikAltered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP InhibitionCancer Research2026Lab ResearchCancer BiologyDNA repair dysfunction and MDC1–ER interaction in invasive lobular carcinoma; homologous recombination impairment and PARP inhibitor sensitivity in ILC models
MarraTracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancernpj Breast Cancer2026ArticleTumor BiomarkersCirculating tumor DNA (ctDNA) for monitoring response to neoadjuvant systemic therapy and predicting relapse risk in stage II–III breast cancer
SafonovHomologous recombination deficiency and hemizygosity drive resistance in breast cancerNature2026ArticleGenomicsHRD; BRCA2 and RB1 loss; CDK4/6 inhibitor resistance; PARP inhibitor sensitivity
AouadPreclinical models of breast cancer metastasis: strengths, limitations, and clinical relevancenpj Breast Cancer2026ReviewMetastasisPreclinical models of breast cancer metastasis, including ILC-relevant models; xenografts; GEMMs; PDX; dormancy; organ tropism; tumor microenvironment
FlahertyLOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular CarcinomaCancer Research2026Lab ResearchCancer BiologyInvasive lobular carcinoma; extracellular matrix (collagen) dependency; LOX inhibition (PXS-5505); integrin signaling (ITGAV/ITGB5); MYC/NF-κB/AP-1 pathways; intraductal xenograft models
CorsoInvasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation statusEuropean Journal of Cancer2026ReviewEpidemiologyGenomics; BRCA1/2 mutation prevalence; ILC vs IDC differences; hereditary risk; genetic testing; subtype-specific risk patterns
SwitallaA prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapyBreast Cancer Research2026ProspectiveImagingFES-PET; ER imaging; neoadjuvant endocrine therapy; ILC imaging response; staging and detection
MukhtarTailoring Management for Invasive Lobular Carcinoma: Imaging, Surgical Treatment, and Systemic Therapy ConsiderationsAmerican Society of Clinical Oncology Educational Book2026ReviewClinicopathologicalILC management; imaging; surgical treatment; systemic therapy
QuinnWorld Health Organization classification of tumours of the breast 6th edition 2026Histopathology2026ReviewClinicopathologicalWHO breast tumour classification; ILC with extracellular mucin; diagnostic classification; biomarkers
CodyQuantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancernpj Breast Cancer2026Lab ResearchMetastasisMisdiagnosis and delayed diagnosis of metastatic ILC; patient-reported experiences; imaging and surveillance
De Laurentiis119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)Miami Breast Cancer Conference Abstracts Supplement2026Conference AbstractClinical TrialsMONALEESA-3 ILC subgroup; ribociclib plus fulvestrant; progression-free and overall survival
RimaMultidimensional Cellular Micro-Compartments to Model Invasive Lobular Carcinoma DormancyAdvanced Healthcare Materials2026Lab ResearchMetastasisILC dormancy; disseminated tumor cell dormancy; anti-estrogen resistance; microfluidic disease modeling
CsakyInvasive lobular carcinoma: Shining a light on the second most prevalent type of breast cancerNurse Practitioner2026ReviewClinicopathologicalILC vs IDC differences; epidemiology; pathology; nursing/clinical awareness
AbelesOmission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast: Rates of Nodal Involvement in Clinically Node Negative Patients and Impact on Recurrence in a Single Institution AnalysisAnn Surg Oncol2026Lab ResearchSurgeryAxillary surgery omission; sentinel lymph node biopsy; nodal involvement; clinically node-negative ILC; recurrence
FasanoClinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular CarcinomaAnn Surg Oncol2026Lab ResearchTreatmentNeoadjuvant systemic therapy; neoadjuvant chemotherapy (NAC); neoadjuvant endocrine therapy (NET); pathologic complete response; sentinel lymph node biopsy; survival and axillary recurrence
DjerroudiInvasive Lobular Carcinoma: Clinicopathologic and Biological InsightsAnnales de Pathologie2026ReviewCancer BiologyClinicopathologic and biological features of ILC; CDH1/E-cadherin loss; metastatic patterns; pathology diagnosis and immunohistochemistry; emerging therapeutic targets
VoorthuisInvasive lobular breast cancer in young patients without adjuvant systemic treatment: 15-year survival outcomesBreast Cancer Research and Treatment2026Lab ResearchIncidenceYoung patients; long-term survival; no adjuvant systemic treatment
MazzoliEffectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2The Breast2026ReviewClinical Trialshistology, metastasis
BoysenRadiation therapy for lobular breast cancer: opportunities and challenges for leveraging radiosensitivityNPJ Breast Cancer2025ReviewTreatmentionizing radiation therapy (XRT)
CorsoInvasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupElsevier2025ReviewTreatment?E-cadherin, endocrine therapy, neoadjuvant treatment
DiamondTargeting DNA Repair Dysfunction in Lobular Breast Cancer by PARP InhibitionEndocrinology2025Lab ResearchCell Signalingcell biology
FoldiPersonalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the BreastJCO Precision Oncology2025RetrospectiveMetastasisctDNA
GuptaInvasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistanceCell Death & Disease2025Lab ResearchTreatment?Endocrine Resistance
HorvatComparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer DetectionRadiology2025ProspectiveImagingcontrast enhanced mammogram, ultrasound
KaurSocioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer DatabaseSpringer Nature2025RetrospectiveEpidemiologyDisparities, Prognosis
KimNode Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular CarcinomaRadiology2025RetrospectiveImagingNode-RADS, lymph node, breast MRI
KnipThe Diagnostic Accuracy of 18F-FDG PET and 18F-FES PET for Staging Grade 1–2 Estrogen Receptor–Positive Breast CancerRadiology2025ProspectiveImagingFES-PET, FDD-PET, ER+, staging
MiddletonImmediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situSpringer Nature2025RetrospectiveTreatment?PLCIS; FLCIS
MouabbiImmediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situBreast Cancer Research and Treatment2025Retrospectivelobular carcinoma in situ, Clinicopathological, PrognosisRecurrence rates
MukhtarSocioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer DatabaseBreast Cancer Research and Treatment2025RetrospectivePrognosisDiagnosis, treatment, outcomes
MukhtarAccuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular CarcinomaAnnals of Surgical Oncology2025RetrospectiveImagingBreast MRI, Neoadjuvant Therapy
MukhtarLocoregional Considerations for Invasive Lobular CarcinomaSpringer Nature2025ReviewSurgeryaxillary management, neoadjuvant therapy
MusickGenetic E-Cadherin Loss Creates a Distinct Phenotype in an Early ILC Tumorigenesis ModelEndocrinology2025Lab ResearchCancer Biologye-cadherin
RaghavendraClinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaJAMA2025RetrospectiveMetastasisclinicopathological, patterns
RätzeAfadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkageJ Pathol2025Lab ResearchCancer Biologye-cadherin
RowlandTranscriptomic Analysis of MDC1 as a Novel Coregulator of Estrogen Receptor in ILCEndocrinology2025Lab ResearchGenomicsER function in ILC
RyuDiagnostic Performance of 18F-Fluoroestradiol PET/CT for Axillary Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Feasibility StudyJNM2025ProspectiveImagingFES PET/CT, metastasis, staging
SandovalPrognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma - an exploratory analysis of the STIC CTC trialClin Cancer Res2025ReviewClinical Trialscirculating tumor cells, metastatis
SikoraEstrogen Receptor co-opts Mediator of DNA Damage Checkpoint 1 (MDC1) to Drive Epigenomic Remodeling and Transcriptional Regulation in ILC CellsEndocrinology2025Lab ResearchCancer Biologyendocrine response and resistance
Singh Parihar18F-Fluorestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor-Positive Breast Cancer: A Systemic Review and MetaanalysisJNM2025RetrospectiveImagingFES PET/CT, endocrine treatment
VertidoAccuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular CarcinomaAnn Surg Oncol2025RetrospectiveImagingMRI, neoadjuvant therapy
ZhangUnique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical ManagementCancers2025ReviewClinicopathologicalpathological classification, CDH1 gene, E-cadherin, tumor biomarkers, clinical managemen
AbigailGlucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtypeJ Steroid Biochem Mol Biol2024Lab ResearchCancer BiologyGlucocorticoid Receptor
AlexanderPathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancerBr J Cancer2024RetrospectiveGenomicsPrognostic Biomarkers
AlkhafajiCirculating tumor cells in early lobular versus ductal breast cancer and their associations with prognosisNpj Breast Cancer2024RetrospectivePrognosisLiquid biopsies
BahlImpact of pre-operative MRI on surgical management of screening digital breast tomosynthesis-detected invasive lobular carcinomaBreast Cancer Res Treat2024RetrospectiveImagingMRI
Balaticohttps://meridian.allenpress.com/aplm/article/148/3/263/499196/Male-Invasive-Lobular-Breast-CancerArch Pathol Lab Med2024RetrospectiveClinicopathologicalMale ILC
BatraExploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular CarcinomaFront Oncol2024Lab ResearchCancer BiologyTumor Microenvironment
BraunsteinAccelerated Partial Breast Irradiation for Early-Stage Invasive Lobular CarcinomaInt J Radiat Oncol Biol Phys2024RetrospectiveRadiation OncologyPartial Breast Radiation
ChengAnalysis of prognostic factors and construction of prognostic models for invasive lobular carcinoma of the breastBiomol Biomed2024Risk FactorsPrognosisProgostic Models
CoffeyBreast Radiologists’ Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is WarrantedJournal of Breast Imaging2024RetrospectiveImagingImaging Methods
CoffeyBreast Radiologists’ Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is Warranted Journal of Breast Imaging2024SurveyImagingBreast Imaging
CorsoCDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeJAMA Netw Open2024ProspectiveGenomicsHereditary CDH1 mutations
De SchepperIntegration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer ConsortiumModern Pathology2024Lab ResearchPathologyDiagnosis, ILC variants
DjerroudiMolecular and Clinical Portrait of HER2-low Invasive Lobular CarcinomasMod Pathol2024RetrospectiveGenomicsHer-2 low ILC
Djerroudihttps://www.modernpathology.org/article/S0893-3952(24)00150-9/fulltextMod pathol2024RetrospectiveClinicopatholgicalCDH1 Mutations
DopesoGenomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterationsnpj Precis. Onc2024Lab ResearchGenomicsCDH1 (lack of)
FaladeVariation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breastBreast Cancer Res Treat2024RetrospectiveSurgeryBody Mass Index
FaladeOncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular CarcinomaAnn Surg Oncol2024RetrospectiveSurgeryOncoplastic Surgery
FlahertyIs There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?Endocrinology2024ReviewRisk FactorsHRT
FoldiLong-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials JNCI2024RetrospectiveClinicopathologicalPrognosis
GeukensRapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation programNpj Breast Cancer2024RetrospectiveMetastasisRapid Autopsy
GiannotiThe role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breastClin Radiol2024RetrospectiveImagingContrast Enhanced Mammography (CEM)
Gonzales-MartinezCDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutationVirchows Arch2024Lab ResearchGenomicsCDh1 Mythelation
GronewoldMicroenvironment‐induced restoration of cohesive growth associated with focal activation of P‐cadherin expression in lobular breast carcinoma metastatic to the colonJ Pathol Clin Res2024RetrospectiveClinicopathologicalColon metastasis
IlićDifferences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular ClassificationDiagnostics (Basel)2024RetrospectiveClinicopathologicalHistological Subtypes of ILC
IzciAdipocyte heterogeneity and tumor infiltration of adipose tissue in patients with metastatic breast cancerBreast2024RetrospectiveMetastasisTumor Infiltratiion
KatayamaNuclear morphological characterisation of lobular carcinoma variants: a morphometric studyHisotpathology2024Lab ResearchClinicopatholgicalPleomorphic Variant
KioleoglouGastrointestinal Metastases From Lobular Breast Carcinoma: A Literature ReviewCureus2024ReviewMetastasisGI Metastasis
KolawoleThe Alveolar Variant of Lobular Carcinoma and Its Mimickers: A Case SeriesCureus2024Case StudiesClinicopathologicalAlveolar Varient
MakhloufDeciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive SubtypeCancers2024RetrospectiveClinicopathologicalILC Variants
MmedCan 18F-FES PET Improve the Evaluation of 18F-FDG PET in Patients With Metastatic Invasive Lobular Carcinoma?Clinical Nuclear Medicine2024RetrospectiveImagingFES/FDG PET
NakagawaPotential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinomaBreast Cancer Res Treat2024RetrospectiveClinicopathologicalEndocrine Resistance
NarayananTranscriptomic analysis identifies enrichment of cAMP/PKA/CREB signaling in invasive lobular breast cancerBreast Cancer Res2024Lab ResearchCancer BiologyCell signaling
O'ConnorEvaluating Surgical Outcomes Between Estrogen Receptor Positive Invasive Lobular and Invasive Ductal Carcinoma of the Breast-A Propensity Matched AnalysisClin Breast Cancer2024RetrospectiveSurgeryPrognosis
OztekinThe effect of neoadjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort studyCancer2024RetrospectiveClinicopathologicalNeo-Adjuvent Chemotherapy
PabbaStromal Tumor-Infiltrating Lymphocytes in Hormone Receptor-Positive/HER2 Negative Metastatic Breast CancerMod Pathol2024RetrospectiveCancer BiologyImmune Landscape
ParejaA Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating MechanismsCancer Res2024Lab ResearchGenomicsArtificial Intelligence
QuirkeInvasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year periodThe Breast2024RetrospectiveClinicopathologicalNeo-Adjuvent Chemotherapy
RoggesPleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation: case report and literature review - PMCPathologica2024Case Studies/ReviewClinicopathologicalMale ILC
ShahSpatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsProc Natl Acad Sci2024ClinicopathologicalCancer BiologyTumor heterogeneity
ShinExpression of PD-L1 in breast invasive lobular carcinomaPLOs One2024Lab ResearchGenomicsPDL-1 Expression; Immuno-oncology
SikoraA Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular CarcinomaJournal of the Endocrine Society2024CommentaryCancer Biologycell signaling
SottnikWNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersCancer Res Commun2024Lab ResearchCancer Biologycell signaling
UchidaInsights into E-Cadherin Impairment in CDH1-Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic StudyInt J Mol Sci2024ClincopathologicalCancer BiologyCDH1 (non-mutated)
UlanerER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast CancerAMA Netw Open2024Diagnostic studyImagingER-Targeted PET
UlanerER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast CancerJAMA Network2024ProspectiveClinical TrialsFES PET/CT, staging
Van BaalenReporting on invasive lobular breast cancer in clinical trials: a systematic reviewNpj Breast Cancer2024ReviewClinicial TrialsUnderreporting ILC, RECiST criteria
Van HemertBreast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcomeBreast Cancer Res Treat2024RetrospectiveSurgeryNeo-Adjuvent Chemotherapy
YatesESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and PhenotypesEndocrinology2024Lab ResearchClinicopathologicalEstrogen Resistance
ZelsMetastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histologyThe Breast2024RetrospectiveMetastasisMixed NST/ILC
ZouSystems approach for congruence and selection of cancer models towards precision medicinePLoS Comput Biol2024Lab ResearchClinicopathologicalCell Models
AliagaEvolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastasesEJC European Journal of Cancer2023RetrospectiveClinicopathologicalPrimary vs Metastatic Tumors
AmirA role for breast ultrasound Artificial Intelligence decision support in the evaluation of small invasive lobular carcinomasClinical Imaging2023RetrospectiveImagingArtificial Inteligence
ArceEvaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital MammographyCureus2023RetrospectiveImagingArtificial Inteligence
BarakatAchieving Intraperitoneal Disease Control Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Two Cases of Metastatic Breast CancerCureus2023Case reportsSurgeryPeritoneal Metastatsis
BarbieriA Rare Case of Duodenal Metastasis from Lobular Breast Cancer: From Diagnosis to SurgeryCase Report Oncology2023Case reportsMetastasisDuodenal Metastasis
BatraLobular Carcinoma of the Breast: A Comprehensive Review with Translational InsightsCancers2023ReviewClinicopathologicalCharacteristics of ILC
BonninPerformance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular CarcinomaJournal of Clinical Medicine2023RetrospectiveImagingFDG PET/CT
BottoniDiagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective studyEur J Nucl Med Mol Imaging2023ProspectiveImagingFES PET/CT
ClellandQuantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomesBreast Canc Res Treat2023RetrospectiveClinocopathologicalER low +
CovingtonProspective Pilot Study of 18F-Fluoroestradiol PET/CT in Patients With Invasive Lobular CarcinomasAJR2023ProspectiveImagingFES PET/CT
DayanEffect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trialsBreast Cancer Research2023RetrospectivePrognosisSUCCESS Trial
EshetThe Role of 68Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast CancerClin Nucl Med2023ProspectiveImagingFAPi Pet/CT
FitzpatrickGenomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotypeNat Commun2023Lab ResearchGenomicsLeptomeningeal Metastasis
GilardiFDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast CarcinomaBiomedicines2023ReviewImagingFDG, FES, FAPi
GiraldiFDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast CarcinomaBiomedicines2023ReviewImagingPET Imaging
GokerTumor-Infiltrating Lymphocytes and PD-L1 Expression in Pleomorphic Lobular Breast CarcinomaCancers2023RetrospectiveClincopathologic/GenomicsPleomorphic ILC
GökerHistologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancerBreast Cancer Res2023RetrospectiveClinicopathologicalPrognosis
GoldhaberIs Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice PatternsAnn Surg Oncol2023RetrospectiveSurgerySentinal node biopsy
JochelsonEditorial: Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancerEuropean Journal of Radiology2023editorialimagingcontrast enhanced mammogram
KaurArea Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and outcomesCancer Epidemiol Biomarkers2023RetrospectiveEpidemiologyTumor Characteristics and outcomes
KawaguchiHigh-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imagingBreast Cancer2023RetrospectiveImagingMRI
LiA study of clinical and molecular characteristics in bilateral primary breast cancerCancer Med2023RetrospectiveCllnicopathologicalBilateral Breast Cancer
LobbesThe performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancerEur J Radiol2023RetrospectiveImagingCEM/MRI
MankoffSummary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PETJNM2023summaryimagingestrogen receptor imaging, practice guidelines, [F18]FES PET
MorrisonBone Marrow Only Metastases from Lobular Carcinoma: Insights into Responses to Endocrine
Therapy		Ann Oncol Case Rep2023Case StudiesMetastasisBone Marrow Metastasis
MouabbiAbsence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinomaEJC European Journal of Cancer2023RetrospectivePrognosisLCIS
MuradaliPreoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice GuidelineCurr Oncol2023ReviewImagingMRI
NasrazadaniMixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinomaBr J Cance2023RetrospectiveClinicopathologicalMixed ILC/IDC
OlukoyaRiluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast CancerJ Endocr Soc2023Lab ResearchCancer Biologycell signaling
OnegaDigital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinomaBreast Cancer Res Treat2023RetrospectiveImagingDigital Mammography/Tomsynthsis
OnkarImmune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentNat Cancer2023Lab ResearchGenomicsImmunology
PeresluchaInvasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology ConcordanceHealthcare2023ReviewImagingMRI vs CEM
PorterGlucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of MetastasesCancers2023Lab ResearchCancer BiologyTumor Microenvironment
RamalingamSuccessful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to TreatmentAnn Surg Oncol2023RetrospectiveSurgeryMenopausal Status
RecordTamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancerNpj Breast Cancer2023RetrospectiveClinicalpathologicalAdjuvent Therapy
RibinkarAssociation between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapyRadiol Oncol2023RetrospectiveGenomicsPik3CA mutations
RothschildPredictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic TherapyAnn Surg Oncol2023RetrospectiveClinicopathologicalLocal Recurrances
RothschildHER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional seriesBreast Cancer Res Treat2023RetrospectiveClinicopathologicalHer2 low
RothschildThe impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer DatabaseEpidemiology2023-surgerymetastasis, overall survival
SflomosOptimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast CarcinomaCancers2023Lab ResearchILC ModelsTNBC-ILC
SijnesaelCanonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological typeJournal of Pathology2023-cancer geneticse-cadherin, gene signature, KART, Kaiso, ER positive HER2 negative
ThillTreatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPALBreast Cancer Res Treat2023ProspectiveClinicopathologicalPrognosis
ThomasRare subtypes of triple negative breast cancer: Current understanding and future directionsNPJ Breast Cancer2023RetrospectiveClinicopathologicalTNBC Subtypes
TrilloEvolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastasesEur J Cancer2023RetrospectiveCancer BiologyPrimary vs metastatic ILC
Van BaelenAssociation of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancerEJC European Journal of Cancer2023RetrospectivePrognosisBody mass Index
VoorwerkPD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. . Nat Cancer2023ProspectiveClinicopathologicalImmunotherapy
WangConstruction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysisCancer Medicine2023RetrospectiveCancer BiologyImmune cells
YuClinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?NPJ Breast Cancer2023RetrospectiveClincopathologic/GenomicsLobular Like IDC's (LMMCA)
AbelThe 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database StudyAnn Surg Oncology2022RetrospectiveClinicopathologicalPrognostic Biomarkers
AlexanderAssessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast CancerCancers (Basel)2022ClinicopathologicalGenomicsE-Cadherin
AllenVIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft modelsBritish Journal of Cancer2022Lab ResearchCancer BiologyILC Models
BahnassyUnlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical ModelsMol Cancer Res2022ReviewCancer BiologyILC Models
BhaludinA review on the added value of whole-body MRI in metastatic lobular breast cancerEur Radiol2022ReviewImagingMRI
Bodopati18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the LiteratureTomography2022Case ReportsImagingOrbital metastases
BusbaitOccult Invasive Lobular Carcinoma: Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical ResectionBreast Cancer2022Case StudyMetastasisSkin Metastasis
ChristgenInter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaJ Pathol Clin Res2022Lab ResearchClinicopathologicalDiagnosis
ConstantiniDiagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral MammographyJ Pers med2022RetrospectiveImagingMRI/CESM
DavisCirculating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerE Bio Medicine2022RetrospectiveMetastasisGenomics, ctDNA
de GregorioThe impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS CBr J Cancer2022ReviewClinicopathologicalChemotherapy
De SchepperResults of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancerMod Pathology2022GuidelinesClinicopathologicalDiagnosis
DjerroudiInvasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?JNCI2022EditorialClinicopathologicalPrognosis
Dołęga-KozierowskiMultimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristicsFront Oncol2022RetrospectiveImagingImaging Modalities/Breast
ElangovanLoss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast CarcinomaMol Cancer Res2022Lab ResearchCancer BiologyE-cadherin and cell signaling
FimereliTiming evolution of lobular breast cancer through phylogenetic analysisEBioMedicine2022RetrospectiveGenomicsMetastasis
FitzpatrickAssessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasisClin Canc Research2022RetrospectiveGenomicsLeptomingeal metastasis
Gomez-CuadradoCharacterisation of the Stromal Microenvironment in Lobular Breast CancerCancers2022Lab ResearchCancer BioligyTumor Microenvironment
GroteERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancerModern Pathology2022RetrospectiveGenomicsERBB2 mutations
LeeChromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomasBreast Cancer Research2022Lab ResearchGenomicsEpigenomics
LeNoue-NewtonNatural History and Characteristics of ERBB2-mutated Hormone Receptor–positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case–control Study from AACR Project GENIEClin Canc Research2022RetrospectiveGenomicsERBB2 mutations
MakowerThe 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysisNPJ Breast2022RetrospectiveClinicopathologicalPrognostic Biomarkers
MouabbiHistology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapiesNPJ Breast Cancer2022RetrospectiveClinicopatholicalTargeted therapy in ILC vs. IDC
MouabbiInvasive lobular carcinoma: an understudied emergent subtype of breast cancerBreast Cancer Res Treat2022ReviewClinicopathologicalCharacteristics of ILC
NardoneA Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerCancer Res2022Lab ResearchCancer BiologyEpigenomics
O'ConnorDifferences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysisBreast2022ReviewSurgeryNeoadjuvent chemotherapy
OesterreichClinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast CancerJNCI2022RetrospectiveClinicopathologicalPrognosis
OkinesClinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experienceBreast Cancer Res Treat2022RetrospectiveClinicopathologicalTNBC, Her2 ILC
RatzeLoss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancerOncogene2022Lab ResearchCancer BiologyE-Cadherin
SunDe novo metastatic lobular breast carcinoma: A population-based study from SEER databaseAsian J Surg2022RetrospectiveMetastasisPrognosis
TsutsuiOrbital metastasis of invasive lobular carcinoma of the breastJ Surg Case Rep.2022Case StudyMetastasisOrbital Metastasis
Van BaelenCurrent and future diagnostic and treatment strategies for patients with invasive lobular breast cancerAnnals of Oncology2022ReviewClinicopathologicalTreatment Strategies
WeiserAdjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysisCancer2022RetrospectiveClinicopathologicalAdjuvent Chemotherapy
ZhangBiomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosisBreast Cancer Res Treat2022RetrospectiveClinicopathologicalPleomorphic ILC
AbelDecreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?NPJ Breast Cancer2021RetrospectiveClinical TrialsRECIST criteria
BergeronTriple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutationsNature2021RetrospectiveGenomicsTriple-negative ILC
ChamalidouSurvival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow upThe Breast2021RetrospectiveClinicopathologicalPrognosis
ChenSingle-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer CellsCancer Res2021Lab ResearchCancer BiologyGenomics
ChristgenLobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of TumorsCancers2021ReviewILC VariantsTumor characteristics, variants, microenvironment
CoccoInvasive Lobular Breast Cancer: Data to Support Surgical Decision MakingAnn Surg Onc2021RetrospectiveSurgeryMRI
ConfortiBiological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsBreast2021RetrospectiveClinicopathologicalTNBC
GambleAssociation Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer RiskJama Surgery2021ProspectiveHereditary RiskGermline CDH1 Mutation
GaoPeritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the LiteratureFrontiers in Endocrinology2021Case ReportMetastasisPeritoneal Metastasis
HeHER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic FeaturesCurr Oncology2021RetrospectiveClinicopathologicalHer2+ ILC
HovisAccuracy of Preoperative Breast MRI versus Conventional Imaging in Measuring Pathologic Extent of Invasive Lobular CarcinomaJournal of Breast Imaging2021RetrospectiveImagingMRI
JenkinsThe 70-gene signature test as a prognostic and predictive biomarker in patients with invasivelobular breast cancerBreast Cancer Res Treat2021RetrospectiveGenomicsGene Signatures
McCart ReedThe Genomic Landscape of Lobular Breast CancerCancers (Basel)2021RetrospectiveGenomicsPrognosis
McCart
Reed		Invasive lobular
carcinoma of the breast: the increasing importance of this special subtype		Breast Cancer Res2021ReviewCancer BiologyGenomics and Pathology of ILC
MillsIncreased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation BrachytherapyThe Oncologist2021RetrospectiveRadiologyRadiation
MohamedThe
overexpression of DNA repair genes in invasive ductal and lobular breast
carcinomas: Insights on individual variations and precision medicine		PLOS One2021RetrospectiveGenomicsDNA damage response
MukhtarChanges
in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery
in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer
Database (NCDB)		Annals of Surg Onc2021RetrospectiveSurgeryNeoadjuvent Therapy Response
MukhtarInvasive
Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future
Directions		Clinical Trials2021ReviewClinicopathologicalClinical Trials
NareshAn unwelcome guest: two cases of colonic metastatic lobular breast cancerJ Surg Case Rep2021Case reportsMetastasisColonic Metastases
NunesPrognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaClin Cancer Res2021RetrospectivePrognosisPrognostic Biomarkers
PateHow Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer ResearchCancers2021ReviewResearchAdvocacy
PramodComprehensive
review of molecular mechanisms and clinical features of invasive lobular
cancer		The Oncologist2021ReviewClinicopathologicalMolecular and clinical features
of ILC
ReedInvasive lobular carcinoma of the breast: the increasing importance of this special subtypeBMC Cancer2021ReviewPathologyHistopathology, microenvironment, clinical trials
RiedlingerTargetable alterations in invasive pleomorphic lobular carcinoma of the breastBreast Cancer Res2021RetrospectiveGenomicsPleomorphic ILC
RomanucciLobular Breast Cancer Conspicuity on Digital BreastTomosynthesis Compared to Synthesized 2D Mammography: A Multireader StudyJ Imaging2021RetrospectiveImagingImaging Modalities
RothschildObesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancerBreast Cancer Res Treat2021RetrospectiveRisk FactorsBMI
SflomosAtlas of Lobular Breast Cancer Models: Challenges and Strategic DirectionsCancers2021ReviewCancer BiologyILC Models
SflomosIntraductal
xenografts show lobular carcinoma cells rely on their own extracellular
matrix and LOXL1		Embo Molecular Med2021Lab ResearchCancer biologyTumor microenvironment
SottnickMediator of DNA damage
checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive
lobular carcinoma of the breast		Mol Cancer Res2021Lab ResearchCancer BiologyEstrogen Receptor
SumanAssociation of
variably methylated tumour DNA regions with overall survival for invasive
lobular breast cancer		Clin Epigenetics2021RetrospectiveGenomicsEpigenomics
TimbresSurvival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma. CancersCancers (Basel)2021RetrospectiveClinicopathologicalPrognosis
TrapaniBenefit
of Adjuvant Chemotherapy in Patients with Lobular Breast Cancer: a Systematic
Review of the Literature and Metanalysis		Cancer Treatment Review2021ReviewClinicopathologicalTherapy Response
Van der
Veen		Extended
gene panel testing in lobular breast cancer		Familial Cancer2021RetrospectiveHereditary Breast CancerGermline (Herditary) Mutations
van MaarenTrends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysisThe Breast2021RetrospectiveIncidenceLCIS
WilsonLobular Breast Cancer-A ReviewFrontiers in Oncology2021ReviewClinicopathologicalMolecular and Clinical features of ILC
WongInfiltrative pattern of metastatic invasive lobular breast carcinoma in the abdomen: a pictorial reviewInsights Imaging2021ReviewImagingAbdominal Metastasis
YadavGermline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastJ Clin onc2021RetrospectiveHereditary RiskGermline Mutations
YasuiExpression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the BreastAm J Surg pathol2021Lab ResearchTumor BiomarkersE-Cadherin
AbdallahMetastatic Breast Lobular Carcinoma to Unusual Sites: A Report of Three Cases and Review of LiteraturesJ Med Cases2020Case ReportMetastasisGI metastases
AbelBreast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greaterAmer J of Surgery2020RetrospectiveSurgeryPrognosis
BergeronAn exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing.J Clin Path2020Case ReportGenomicsMetaplastic Carcinoma
BlohmerPatient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histologyBreast Cancer Res2020RetrospectiveMetastasisOribital Metastasis
CarbogninTargeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model.Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelBreast2020Lab ResearchGenomicsPrognosis
ChristgenDifferential impact of prognostic parameters in hormone receptor-positive lobular breast
cancer		Cancer2020RetrospectiveClinicopathologicalPrognostic Biomarkers
Findlay-ShirrasPopulation Trends in Lobular Carcinoma of the Breast: The Ontario ExperienceAnn Surg Oncol2020RetrospectiveClinicopathologicalPrognosis
GrabenstetterE-cadherin
immunohistochemical expression in invasive lobular carcinoma of the breast:
correlation with morphology and CDH1 somatic alterationsE-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations		Human Pathology2020RetrospectiveClinicopathologicale-Cadherin/CDH1
HuAdjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER databaseBMC Cancer2020RetrospectiveClinicopathologicalChemotherapy
KarjolBladder
Metastasis from Breast Cancer: A Systematic Review		Cereus2020ReviewClinicopathologicalBladder Metastasis
KeeHuman epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experienceWorld J Clin Oncol2020RetrospectiveClinicopathologicalHER2+ ILC
KlarenbeekResponse of
metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly
mediated by the adaptive immune system		Oncoimmunology2020Lab ResearchCancer BiologymTor Inhibition
KurozumiTargetable ERBB2
mutation status is an independent marker of adverse prognosis in estrogen
receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a
retrospective in silico analysis of public datasets		Breast Cancer Research2020RetrospectiveCancer BiologyERBB2/Her2 mutations
LaenkholmPopulation-based Study of
Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen
Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal
Breast Cancer.		Clin Breast Cancer2020RetrospectiveGenomicsPrognostic Biomarkers
MontanaghInvasive lobular
carcinoma with papillary features: A newly described variant that poses a
difficult histologic differential diagnosis.		Breast J2020Case ReportClinicopathologalPapillary Carcinoma
MukhtarMitotic Score and
Pleomorphic Histology in Invasive Lobular Carcinoma of the Breast: Impact on
Disease-Free Survival		Breast Cancer Res Treat2020RetrospectiveClinicopathologicalPleomorphic ILC
NarbeThe Distribution of
Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal
Carcinoma of the Breast-Long-Term Prognostic Significance		Cells2020RetrospectiveMetastasisCirculating Tumor Cells
OrlandiPalbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesJ Pers med2020RetrospectiveClinicopathologicalMetastatic ILC
ParejaThe genomic landscape of metastatic histologic special types of invasive breast cancernpj breast cancer2020RetrospectiveGenomicMutations in Metastatic ILC
RichardCharacterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast CancerClin Cancer Research2020Lab ResearchGenomicsMutations in metastatic ILC
SchipperTruncated
ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via
Distinct Mechanisms		Cancer Res2020Lab ResearchCancer BiologyLab Models
SestakPrognostic
Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative
Invasive Lobular Breast Cancer		Clin Cancer Res2020RetrospectivePrognosisPrognostic Biomarkers
ShacklefordEstrogen
Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular
Carcinoma Cell Lines Requires WNT4		Cancers2020Lab ResearchCancer biologyEstrogen signaling
ShamirGenetic analysis of
pleomorphic and florid lobular carcinoma in situ variants: frequent
ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma
in situ and invasivelobular carcinoma		Mod Pathol2020RetrospectiveGenomicsERBB2/3(Her2) mutation in
Pleomorphic and Florid LCIS/ILC
SonOncological
Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of
the Breast: A 20-Year Institutional Experience		Ann Surg Onc2020RetrospectiveSurgerySurgical Methods
SreekumarDifferential
regulation and targeting of estrogen receptor α turnover in invasive
lobular breast carcinoma		Endocrinology2020Lab ResearchCancer BiologyEndocrine Response (SERDS)
TilleTumor-infiltrating
lymphocytes are associated with poor prognosis in invasive lobular breast
carcinoma		Mod Pathol2020RetrospectiveCancer BiologyImmunology
UlanerHead-to-head evaluation of
18F-FES and 18F-FDG PET/CT in metastatic invasive lobular breast cancer		J Nu Med2020ReviewImagingFES PET/CT
WatanukiImpact of neoadjuvant and
adjuvant chemotherapy on invasive lobular carcinoma: A propensity
score-matched analysis of SEER data		Breast J2020RetrospectiveClinicopathologicalChemotherapy
WesthoffPrognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breastVirchous Archiv2020RetrospectiveClinicopathologicalTumor Microenvironment
YangComparison of
Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive
Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER
Database		Frontiers in Cancer2020RetrospectiveClinicopathologicalPrognosis
CaoFrequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaCancer Letter2019Lab ResearchCancer biologyGenomics
ConfortiEndocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrenceBreast Cancer Res2019RetrospectiveRisk FactorsLate Recurrence/Metastasis
CoronaManagement of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancersBreast Cancer Res Treat2019RetrospectiveSurgeryLymph node metastasis
CrownIntraoperative radiation therapy in early-stage breast cancer: Presence of lobular features is not associated with increased rate of requiring additional therapy.Am J Surg2019RetrospectiveSurgeryIntra-operative Radiation
DaniaAssociations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situBreast Cancer Res2019RetrospectiveRisk FactorsRace/Ethnicity
DavisAssociation of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerBreast Cancer Research2019ProspectiveMetastasisLiquid biopsies
de NonnevilleAdjuvant Chemotherapy in Lobular Carcinoma of the Breast: A Clinicopathological Score Identifies High-Risk Patient With Survival BenefitBreast Cancer Res2019RetrospectiveClinicopathologicalChemotherapy
DesmedtESR1 mutations in metastatic lobular breast cancer patientsnpj Breast Cancer2019RetrospectiveGenomicsESR1 Mutation
DessauvagieInvasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostainingPathology2019RetrospectiveClinicopathologicalKi67
DiPiroLobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognosticsignificanceAbdom Radiology2019RetrospectiveMetastasisAbdominal Metastasis
Flores-DiazImpact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patientsBreast Cancer Res Treat2019RetrospectiveClinicopathologicalPrognosis
FranzoiLeptomeningeal
carcinomatosis in patients with breast cancer.		Crit Rev Oncol Hematol2019ReviewMetastasisLeptomeningal Metastasis
GaoCDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancerLancet Oncol2019RetrospectiveClinicopathologicalCDK4/6 inhibitor response
HarrisonGenomic profiling of
pleomorphic and florid lobular carcinoma in situ reveals highly recurrent
ERBB2 and ERRB3 alterations		Mod Pathol2019RetrospectiveGenomicsERBB2 ,ERBB3/(Her2) Mutations
KutasovicBreast cancer
metastasis to gynaecological organs: a clinico‐pathological and
molecular profiling study		J Pathol Clin Res2019RetrospectiveGenomicsGynocological Metastasis
LevineFGFR4
overexpression and hotspot mutations in metastatic ER+ breast cancer are
enriched in the lobular subtype		NPJ Breast Cancer2019Lab ResearchGenomicsMetastasis
LuvetaInvasive
Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic
Strategy		Oncol and Therapy2019ReviewCancer BiologyGenomics and Therapeutic strategies
MamtaniLobular
Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG
Z0011-Eligible Breast Cancer		Ann Surg Oncol2019RetrospectiveSurgeryLymph Node Dissection
McCart
Reed		LobSig is a
multigene predictor of outcome in invasive lobular carcinoma		NPJ Breast Cancer2019Lab ResearchGenomicsGene signatures
PetridisFrequency of Pathogenic
Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic
Lobular Breast Cancer		Cancer Epidemiol Biomark2019RetrospectiveGenomicsGenetic basis of ILC
Rosa-RosaHigh Frequency
of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with
Pleomorphic Features		Cancers2019RetrospectiveCancer biologyHer2(ERBB2) mutation in PLC
TamarisaThe impact of
chemotherapy sequence on survival in node-positive invasive lobular carcinoma		J Surg Onco2019RetrospectiveClinicopathologicalChemotherapy
ThomasInvasive lobular breast
cancer: A review of pathogenesis, diagnosis, management, and future
directions of early stage disease		Semin Oncol2019ReviewClinicopathologicalNeoadjuvant Therapy
ThorntonNeoadjuvant Endocrine
Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular
Carcinoma		Ann Surg Oncol2019RetrospectiveClinicopathologicalNeoadjuvent Therapy Response
WalshBET Inhibition as a
Rational Therapeutic Strategy for Invasive Lobular Breast Cancer.		Clin Can Res2019Laboratory ResearchCancer BiologyNovel therapeutics
WilliamsDifferences in
race, molecular and tumor characteristics among women diagnosed with invasive
ductal and lobular breast carcinomas		Cancer Causes2019RetrospectiveClinicopathologicalRacial Differences in ILC vs IDC
XicolaClinical features and
cancer risk in families with pathogenic CDH1 variants irrespective of
clinical criteria		J Med Genet2019RetrospectiveClinicopathologicalGenetic basis of ILC
AdachiComparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinomaBreast Cancer2018RetrospectiveSurgerySentinal Lymph Node biopsy
AnCdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastCell Reports2018Laboratory ResearchGenomicsLab Models
BajramiE-cadherin/ROS1 inhibitor synthetic lethality in breast cancerCancer Disc2018Lab ResearchCancer BiologyE-cadherin
BrunerLoss of E-Cadherin-Dependent Cell–Cell Adhesion and the Development and Progression of CancerCSH Perspectives2018ReviewCancer BiologyE-cadherin
Chen21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancerBiomarkers in Medicine2018RetrospectiveGenomicsPrognostic Biomarkers
CorsoHereditary lobular breast cancer with an emphasis on E-cadherin genetic defectJ Med Genet2018ReviewHereditary breast cancerGermline CDH1 mutation
Da RosHER2-positive lobular versus ductal carcinoma of the breast: pattern of first recurrence and molecular insights. Clin Breast Cancer2018RetrospectiveClinicopathologicalHer2+ ILC
de grootαE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancerJ Pathology2018Lab ResearchCancer BiologyE-cadherin
DesmedtImmune Infiltration in Invasive Lobular Breast CancerJ Natl Cancer Inst.2018RetrospectiveCancer biologyImmunology
DitchiLow risk of invasive lobular carcinoma of the breast in carriers of BRCA1 and TP53 (Li-Fraumeni syndrome) germline mutationsBreast Journal2018RetrospectiveHereditary breast cancerBRCA / p53 mutation
DonaldsonBreast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsyCancer2018RetrospectiveRisk FactorsLCIS/Hyperplasia
DuKey regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancerBreast Cancer Research2018Lab ResearchCancer biologyEndocrine Resistance
GuvenSentinel Lymph
Node Metastasis in Invasive Lobular Carcinoma of the Breast		European Journal Br Helath2018RetrospectiveMetastasisLymph Node Invasion
HaBreast MR Imaging
before Surgery: Outcomes in Patients with Invasive Lobular Carcinoma by Using
Propensity Score Matching		Radiology2018RetrospectiveImagingMRI
LiaoThe
Clinicopathological Features and Survival Outcomes of Different Histological
Subtypes in Triple-negative Breast Cancer		J Cancer2018RetrospectiveClinicopathologicalTriple-negative ILC
MamtaniLobular Breast Cancer
Different Disease, Different Algorithms		Surgical Oncol Cinics2018ReviewClinicopathologicalGenomics of ILC
McCart
Reed		Mixed
ductal-lobular carcinomas: evidence for progression from ductal to lobular
morphology		J Pathology2018RetrospectiveCancer biologyMixed ILC/IDC
Metzger-FilhoMixed Invasive
Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of
Histologic Grade		The Oncologist2018RetrospectiveClinicopathologicalMixed ILC/IDC
MontagnaLobular Metastatic
Breast Cancer Patients With Gastrointestinal Involvement: Features and
Outcomes		Clinical Breast Cancer2018RetrospectiveMetastasisMetastatic Sites
MukhtarBreast Conservation and
Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic
Surgery and Shave Margins in 358 Patients		Annals of Surgical Oncol2018RetrospectiveSurgerySurgical methods
NagleLoss of
E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast
Cancers to Anti-IGF1R/InsR Inhibitors		Clinical Cancer Research2018Laboratory ResearchCancer biologyCell signaling
OesterreichOpening the
Door for Immune Oncology Studies in Invasive Lobular Breast Cancer		J Natl Cancer Inst.2018EditorialCancer biologyImmunology
PatelValue Added of
Preoperative Contrast-Enhanced Digital Mammography in Patients With Invasive
Lobular Carcinoma of the Breast		Clinical Breast Cancer2018RetrospectiveImagingMammography methods
Perez-GarciaEfficacy of Single-Agent
Chemotherapy for Patients with Advanced Invasive LobularCarcinoma		The Oncologist2018RetrospectiveClinicopathologicalChemotherapy
PhalakSupplemental ultrasound
screening in patients with a history of lobular neoplasia		The Breast Journal2018RetrospectiveImagingLobular Neoplasia
SokolLoss of function
of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular
breast cancer		Ann Oncol2018Lab ResearchGenomicsEndocrine Resistance
StiresIntegrated
Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer
Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities		Mol Cell Endocrin2018Lab ResearchCell SignalingEndocrine Resistance
Strasser-WeipplOutcomes in women with
invasive ductal or invasive lobular early stage breast cancer treated with
anastrozole or exemestane		European Journal of Cancer2018RetrospectiveClinicopathologicalEndocrine Therapy
TasdemirComprehensive
phenotypic characterization of human invasive lobular carcinoma cell lines in
2D and 3D cultures		Cancer Resarch2018Lab ResearchCancer biologyLab models
TeoE-cadherin loss
induces targetable autocrine activation of growth factor signalling in
lobular breast cancer		Scientific Reports2018Lab ResearchCancer biologyCell signaling
WangThe Distribution
and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen
Receptor-Positive Breast Cancer With Different Histologic Subtypes		Frontiers in Genetics2018RetrospectiveGenomicsPrognostic Biomarkers
WenLobular Cancer in SituSurg Pathol Clin2018RetrospectiveClinicopathologicalRisk Factors
WongEvaluating the Impact of
Breast Density on Preoperative MRI in Invasive Lobular Carcinoma		J Am Coll Surg2018RetrospectiveImagingMRI
BagliaAlcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 YearsHormones and Cancer2017RetrospectiveRisk FactorsAlcohol use
ChenInvasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinomaPLOS One2017RetrospectiveClinicopathologicalPrognosis
ChristgenSubclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinomaJ Patho Clin Res2017Case ReportGenomicsPapillary Carcinoma
CostarelliPleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?Breast Cancer2017RetrospectiveCancer biologyPleomorphic ILC
FeltsAn Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.Breast j2017RetrospectiveGenomicsPrognostic Biomarkers
HarrellEstrogen induces
c-Kit and an aggressive phenotype in a model of invasive lobular breast
cancer		Oncogeniesis2017Lab ResearchCancer BiologyEstrogen signaling
HoussamiMeta-analysis of
pre-operative magnetic resonance imaging (MRI) and surgical treatment for
breast cancer		Breast Canc Res Treat2017ReviewImagingMRI
InoueSpecific sites of
metastases in invasive lobular carcinoma: a retrospective cohort study of
metastatic breast cancer		Breast Cancer2017RetrospectiveMetastasisMetastatic Sites
KizyImpact of the 21-gene
recurrence score on outcome in patients with invasive lobular carcinoma of
the breast		Breast Cancer Res2017RetrospectiveGenomicsPrognostic Biomarkers
LienFrequent alterations of
HER2 through mutation, amplification, or overexpression in pleomorphic
lobular carcinoma of the breast.		Breast Canc Res Treat2017RetrospectiveGenomicsHER2+ and mutations in PLC
MarmorRelative
Effectiveness of Adjuvant Chemotherapy for Invasive Lobular Compared With
Invasive Ductal Carcinoma of the Breast		Cancer2017RetrospectiveClinicopathologicalChemotherapy
MathewDistinct Pattern
of Metastases in Patients with Invasive Lobular Carcinoma of the Breast		Geburtshilfe Frauenheilkd2017RetrospectiveMetastasisMetastatic Sites
RaapLobular carcinoma in
situ and invasive lobular breast cancer are characterized by enhanced
expression of transcription factor AP-2β.		Lab Invest2017Lab ResearchCancer BiologyGenomics of ILC
SahinInvasive Pleomorphic
Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients
with Breast Cancer		Am Surg2017RetrospectiveClinicopathologicalPleomorphic ILC
SengerInvasive lobular
carcinoma of the male breast – a systematic review with an illustrative
case study		Breast Cancer2017Case ReportClinicopathologicalMale ILC
ShahPIK3CA mutations
are common in lobular carcinoma in situ, but are not a biomarker of
progression		Breast Cancer Res2017RetrospectiveGenomicsPIK3CA mutations in LCIS
UlanerProspective Clinical
Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant
Therapy in IDC and ILC		Journal of Nuclear Medicine2017ProspectiveImaging18 F-Fluciclovine PET/CT
Venema18F-FES PET Has Added
Value in Staging and Therapy Decision Making in Patients With Disseminated
Lobular Breast Cancer.		Clin Nucl Med2017Laboratory ResearchImagingFES PET
XiaoMixed invasive
ductal and lobular carcinoma has distinct clinical features and predicts
worse prognosis when stratified by estrogen receptor status		Scientific reports2017RetrospectiveClinicopathologicalMixed IDC/ILC
AbreuInvasive lobular carcinoma: a rare presentation in the male breastBMJ Case report2016Case ReportClinicopathologicalMale ILC
AdachiComparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinomaBMC Cancer2016RetrospectiveClinicopathologicalPrognosis
Barroso-SousaDifferences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsAdv Med Onc2016ReviewClinicopathologicalTherapy Response and Resistance
BeumerPrognostic Value of MammaPrint® in Invasive Lobular Breast CancerBiomark Insights2016RetrospectiveClinicopathologicalPrognostic Biomarkers
ChristgenLobular breast cancer: Clinical, molecular and morphological characteristicsPathology2016ReviewCancer biologyPathology
CorsoCDH1 germline mutations and hereditary lobular breast cancer.Fam Cancer2016ReviewHereditary breast cancerGermline CDH1 mutation
DeniziatERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomasOncotarget2016RetrospectiveGenomicsERBB2(HER2) Somatic Mutations
DesmedtGenomic Characterization of Primary Invasive Lobular Breast CancerJournal of Clinical Oncology2016Lab ResearchGenomicsMutations in ILC
HornsveldRestraining
FOXO3-dependent transcriptional BMF activation underpins tumour growth and
metastasis of E-cadherin-negative breast cancer		Cell Death Diff2016Lab ResearchCancer BiologyMetastasis /E-cadherin
LanglandsContralateral breast
cancer: incidence according to ductal or lobular phenotype of the primary		Clinical Radiology2016RetrospectiveClinicopathologicalContralateral Breast Cancer
MichautIntegration of
genomic, transcriptomic and proteomic data identifies two biologically
distinct subtypes of invasive lobular breast cancer		Sci Rep2016Lab ResearchGenomicsGenetic basis of ILC
SikoraWNT4 mediates
estrogen receptor signaling and endocrine resistance in invasive lobular
carcinoma cell lines		Breast Cancer Res2016Lab ResearchCancer biologyEndocrine response and resistance
SledgeCollective
Wisdom: Lobular Carcinoma of the Breast		ASCO2016ReviewCancer biologyTherapy response and resistance
Tenhagenp120-Catenin Is
Critical for the Development of Invasive Lobular Carcinoma in Mice		J Mamm Gland Biol Neo2016Lab ResearchCancer BiologyP120 Catenin
TruinDifferences in
Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive
Lobular Versus Ductal Breast Cancer		Annals of Surgical Oncol2016RetrospectiveClinicopathologicalNeoadjuvent Chemotherapy
BertozziPrevalence, risk factors, and prognosis of peritoneal metastasis from breast cancerSpringer Plus2015RetrospectiveMetastasisPeritoneal Metastasis
ChristgenLobular breast cancer: molecular basis, mouse and cellular modelsBreast Cancer Res2015ReviewCancer biologyILC Models
CirielloComprehensive Molecular Portraits of Invasive Lobular Breast CancerCell2015Lab ResearchGenomicsGenetic basis of ILC
DashevskyAppearance of untreated bone metastases from breast cancer on FDG PET/CT: Importance of histologic subtypeEur J Nucl Med Mol Imaging2015RetrospectiveImagingBone Metastases
DossusLobular breast cancer: incidence and genetic and non-genetic risk factorsBreast Cancer Research2015ReviewRisk FactorsIncidence
EngstromInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypesHistopathology2015RetrospectiveClinicopathologicalPrognosis
HansfordHereditary
Diffuse Gastric Cancer Syndrome -CDH1 Mutations and Beyond		Jama Oncol2015RetrospectiveHereditary breast cancerGenetic CDH1 mutation
HoganComparison of
18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular
Carcinoma Versus Invasive Ductal Carcinoma		J Nucl Med2015RetrospectiveImagingFDG PET/CT
JacobsIssues Affecting the
Loco-regional and Systemic Management of Patients with Invasive Lobular
Carcinoma of the Breast		The Breast Journal2015ReviewClinicopathologicalTherapy Response and Resistance
JohnsonLobular breast cancer
series: imaging		Breast Cancer Res2015ReviewImagingImaging Modalities
LoganMolecular
drivers of lobular carcinoma in situ		Breast Cancer Res2015ReviewCancer biologyLCIS
LokadasanMetastatic
lobular carcinoma of breast mimics primary cervix carcinoma: two case reports
and a review of the literature		ecancermedicalscience2015Case ReportMetastasisCervical Metastasis
McCart
Reed		An epithelial to mesenchymal
transition programme does not usually drive the phenotype of invasive lobular
carcinomas		J Pathology2015Lab ResearchCancer BiologyE-Cadherin
McCart
Reed		Invasive lobular
carcinoma of the breast: morphology, biomarkers and Õomics		Breast Cancer Research2015ReviewCancer biologyGenomics
Metzger-FilhoRelative
Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular
Carcinoma in the BIG 1-98 Trial		Journal of Clinical Oncology2015RetrospectiveClinicopathologicalEndocrine Therapy
RaapHigh frequency
of lobular breast cancer in distant metastases to the orbit		Cancer Med2015RetrospectiveMetastasisOribital Metastasis
SwitzerCase
series of 21 patients with extrahepatic metastatic lobular breast carcinoma
to the gastrointestinal tract		Cancer Treat Comm2015Case ReportMetastasisGI Metastasis
van de VenNuclear
p120-catenin regulates the anoikis resistance of mouse lobular breast cancer
cells through Kaiso-dependent Wnt11 expression		Dis Model Mech2015Lab ResearchCancer BiologyP120 Catenin
van der
Post		Hereditary
diffuse gastric cancer: updated clinical guidelines with an emphasis on
germline CDH1 mutation carriers		J Med Genet2015ReviewRisk FactorsHereditary CDH1 Mutation
ArthurMolecular Changes in Lobular Breast Cancers in Response to Endocrine TherapyCancer Res2014RetrospectiveGenomicsEndocrine Therapy
GuiuInvasive lobular breast
cancer and its variants: how special are they for systemic therapy decisions		Crit Rev Onco Hematology2014ReviewClinicopathologicalTherapy Response and Resistance
HeDistant
Metastatic Disease Manifestations in Infiltrating Lobular Carcinoma of the
Breast		AJR2014ReviewMetastasisMetastatic Sites
NarbeInvasive lobular
carcinoma of the breast: long-term prognostic value of Ki67 and histological
grade, alone and in combination with estrogen receptor		Springer Plus2014RetrospectiveClinicopathologicalPrognosis/Ki67
OliveraEvolving
concepts in breast lobular neoplasia and invasive lobular carcinoma, and
their impact on imaging methods		Insights Imaging2014ReviewImagingImaging modalities
SawyerGenetic
Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast		PLOS2014RetrospectiveGenomicsGenetic Basis of ILC/LCIS
SikoraInvasive lobular
carcinoma cell lines are characterized by unique estrogen-mediated gene
expression patterns and altered tamoxifen response		Cancer Resarch2014Lab ResearchCancer biologyEndocrine response and resistance
ChristgenOncogenic PIK3CA Mutations in Lobular Breast Cancer ProgressionGenes Chromosones Cancer2013RetrospectiveGenomicsPIK3CA Mutations
DelpechClinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasBritish Journal of Cancer2013RetrospectiveClinicopathologicalChemotherapy
IshidaPleomorphic
lobular carcinoma in a male breast: a case report with review of the
literature		Int J Clin Exp Pathol2013Case ReportClinicopathologicalMale ILC
KorhonenThe
impact of lobular and ductal breast cancer histology on the metastatic
behavior and long term survival of breast cancer patients		The Breast2013RetrospectiveClinicopathologicalMetastasis
Metzger-FilhoMagnitude of
trastuzumab benefit in patients with HER2-positive, invasive lobular breast
carcinoma: results from the HERA trial		Journal of Clinical Oncology2013RetrospectiveClinicopathologicalHER2+ ILC
Metzger-FilhoGenomic grade adds
prognostic value in invasive lobular carcinoma		Ann Onc2013RetrospectiveGenomicsGene Signatures
MotenCharacterizing lobular
carcinoma of the male breast using the SEER database.		J surg Res2013RetrospectiveClinicopathologicalMale ILC
RossRelapsed
Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows
a High Frequency of HER2 (ERBB2) Gene Mutations		Clinical Cancer Research2013RetrospectiveGenomicsHER2(ERBB2) Mutation in iLC
VlugNuclear
localization of the transcriptional coactivator YAP is associated with
invasive lobular breast cancer		Cell Oncol2013Laboratory ResearchCancer BiologyCell Signaling
BrunelloFGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinomaJ Exp Clin Cancer Res2012RetrospectiveGenomicsFGFR1 mutation
CarcoforoInfiltrating Lobular Carcinoma of the Breast Presenting as Gastrointestinal Obstruction: A Mini ReviewJournal of Cancer2012Case ReportMetastasisGI Metastasis
GainerInvasive Lobular
Carcinoma Predicts Micrometastasis in Breast Cancer		Journal or Surgical Research2012Lab ResearchCancer biologyMetastasis
IorfidaInvasive lobular breast
cancer: subtypes and outcome		Breast Cancer Res Treat2012RetrospectiveClinicopathologicalPrognosis
SikoraInvasive lobular
carcinoma of the breast: Patient response to systemic endocrine therapy and
hormone response in model systems		Steroids2012ReviewCancer biologyEndocrine Resistance
van de
Water		Influence
of semi-quantitative oestrogen receptor expression on adjuvant endocrine
therapy efficacy in ductal and lobular breast cancer		Eur J Cancer2012RetrospectiveClinicopathologicalAdjuvent Endocrine Therapy
DerksenMammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceDis Model Mech2011Lab ResearchCancer Biology ILC Models
DixonInvasive lobular carcinoma: response to neoadjuvant letrozole therapyBreast Cancer Res Treat2011RetrospectiveClinicopathologicalEndocrine Resistance
PatelCT, MRI and PET imaging in peritoneal malignancyCancer Imaging2011ReviewImagingPeritoneal Metastasis
SchackmannCytosolic
p120-catenin regulates growth of metastatic lobular carcinoma through
Rock1-mediated anoikis resistance		J Clin Invest2011Lab ResearchCancer BiologyP120-Catenin
YuClassical-type
invasive lobular carcinoma with HER2 overexpression: clinical, histologic,
and hormone receptor characteristics		Am J Clinical Path2011Case ReportCancer biologyHER2 in ILC
AnwarInvasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?Intl J Surg2010RetrospectiveClinicopathologicalPrognosis
PhippsRisk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationCancer Epidemiol Biomarkers Prev2010RetrospectiveClinicopathologicalRisk Factors
LopezInvasive Lobular
Carcinoma of the Breast: Spectrum of Mammo- graphic, US, and MR Imaging
Findings		Radiographics2009ReviewImagingImaging modalities
VargasPleomorphic lobular
carcinoma of the breast: molecular pathology and clinical impact		Future Oncol2009ReviewGenomicsPleomorphic ILC
MannMRI compared to
conventional diagnostic work-up in the detection and evaluation of invasive
lobular carcinoma of the breast		Breast Cancer Res2008ReviewImagingMRI
OrvietoClinicopathologic
characteristics of invasive lobular carcinoma of the breast		Cancer2008RetrospectiveClinicopathologicalPrognosis
PestalozziDistinct
Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the
Breast: Combined Results of 15 International clinical trials		J Clin Oncol2008RetrospectiveClinicopathologicalPrognosis
RakhaInvasive lobular
carcinoma of the breast: response to hormonal therapy and outcomes		Eur J Cancer2008RetrospectiveClinicopathologicalAdjuvent Endocrine Therapy
RigginsERRγ
mediates Tamoxifen resistance in novel models of invasive lobular breast
cancer		Cancer Res2008Lab ResearchCancer biologyEndocrine Resistance
ShraderHereditary
diffuse gastric cancer: association with lobular breast cancer		Fam Cancer2008Case ReportClinicopathologicalHerditary CDH1 mutation
DabbsLobular versus ductal breast neoplasms: the diagnostic utility of p120 cateninAm J Surg Path2007RetrospectiveClinicopathologicalP120-Catenin
XinA review of invasive lobular
carcinoma of the breast: Should it be treated like invasive ductal carcinoma?		Integr Cancer Sci Therapy2007ReviewClinicopathologicalPrognosis
DerksonSomatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisCancer Cell2006Lab ResearchCancer BiologyILC Models
Reis-FilhoFGFR1
Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas		Clin Can Res2006RetrospectiveGenomicsFGFR1 mutation
StangeHigh-Resolution
Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and
16p with Histologic and Genetic Subgroups of IBC cell lines		Clinical Cancer Research2006RetrospectiveGenomicsGenomics of ILC
TalmanInvasive
lobular breast cancer. Prognostic significance of histological malignancy
grading		Acta Onc2006RetrospectiveClinicopathologicalPrognosis
ChristofanilliInvasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival OutcomesJournal of Clinical Oncology2005RetrospectiveClinicopathologicalChemotherapy
SingletaryTreatment Trends
in Early-Stage Invasive Lobular Carcinoma		Ann Surgery2005RetrospectiveSurgerySurgical Methods
ArpinoInfiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeBreast Cancer Research2004RetrospectiveClinicopathologicalCharacteristics of ILC
BergDiagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancerRadiology2004RetrospectiveImagingImaging Methods
MathieuThe poor responsiveness
of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be
explained by their biological profile		Eur J Cancer2004RetrospectiveClinicopathologicalChemotherapy
SelinkoRole of sonography in
diagnosing and staging invasive lobular carcinoma		J Clin Ultrasound2004RetrospectiveImagingImaging Methods
LiHormone replacement
therapy in relation to risk of lobular and ductal breast carcinoma in
middle-aged women.		Cancer2000RetrospectiveRisk FactorsHormone Replacement Therapy
LiChanging Incidence Rate
of Invasive Lobular Breast Carcinoma among Older Women		Cancer2000RetrospectiveRisk FactorsIncidence
WinstonMetastatic
Lobular Carcinoma of the Breast: Patterns of Spread in the Chest, Abdomen,
and Pelvis on CT		AJR2000RetrospectiveMetastasisMetastatic sites
Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

Join Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*